share_log

CVS Health | DEF 14A: Definitive information statements

SEC announcement ·  Apr 5 16:10
Summary by Moomoo AI
CVS Health Corporation (CVS Health) is set to hold its Annual Meeting of Stockholders on May 16, 2024, at 8:00 a.m. Eastern Time. The meeting will be conducted virtually to allow shareholders to participate regardless of their location. The agenda includes the election of directors, ratification of the independent registered public accounting firm for 2024, advisory approval of executive compensation, and a proposal to amend the 2017 Incentive Compensation Plan to increase the number of shares authorized for issuance. Additionally, four stockholder proposals will be considered, including an independent worker rights assessment, a policy to prohibit re-nomination of directors failing to receive a majority vote, a vote on 'excessive' golden parachutes, and a policy requiring directors to disclose their time allocation among commitments...Show More
CVS Health Corporation (CVS Health) is set to hold its Annual Meeting of Stockholders on May 16, 2024, at 8:00 a.m. Eastern Time. The meeting will be conducted virtually to allow shareholders to participate regardless of their location. The agenda includes the election of directors, ratification of the independent registered public accounting firm for 2024, advisory approval of executive compensation, and a proposal to amend the 2017 Incentive Compensation Plan to increase the number of shares authorized for issuance. Additionally, four stockholder proposals will be considered, including an independent worker rights assessment, a policy to prohibit re-nomination of directors failing to receive a majority vote, a vote on 'excessive' golden parachutes, and a policy requiring directors to disclose their time allocation among commitments. The Board of Directors recommends voting for the election of directors, ratification of the accounting firm, executive compensation, and the amendment to the incentive plan, and against all stockholder proposals. The meeting will also include a business presentation and a Q&A session. Shareholders as of the record date, March 18, 2024, are entitled to vote and have been provided with various methods to submit their votes.

This announcement is a separate document:

Doc 1

Doc 2

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more